Chat with GenHealth to automate any coding or chart task.
Isovaleric Acidemia (ICD-10-CM Code: E71.110)
Name of the Condition
- Isovaleric acidemia.
Summary
Isovaleric acidemia is an inherited metabolic disorder characterized by the body's inability to properly break down the branched-chain amino acid leucine. This disruption leads to the accumulation of toxic byproducts, such as isovaleric acid, which can cause neurological and systemic complications if not managed.
Causes
Genetic mutations affecting the isovaleryl-CoA dehydrogenase enzyme, which is essential for leucine catabolism. The disorder is typically inherited in an autosomal recessive pattern, meaning both parents must carry a mutated gene for the condition to manifest.
Risk Factors
- Family history of metabolic disorders.
- Consanguinity (parents who are closely related).
- Certain ethnic populations with higher carrier rates for specific mutations.
Symptoms
- Developmental delay or regression.
- Lethargy or poor feeding in infants.
- Vomiting or poor weight gain.
- Neurological symptoms, such as seizures or abnormal muscle tone.
- Metabolic crises, including ketoacidosis or hyperammonemia, in severe cases.
Diagnosis
Diagnosis involves biochemical testing to measure organic acid levels in urine or blood, often supplemented by genetic testing to identify specific mutations. Newborn screening may detect elevated isovalerylcarnitine levels.
Treatment Options
- Dietary management to limit leucine intake.
- Supplementation with glycine or carnitine to aid detoxification.
- Regular monitoring of metabolic status and nutritional needs.
- Prompt treatment of metabolic crises with intravenous fluids and medications.
Prognosis and Follow-Up
With early diagnosis and consistent management, individuals may lead relatively normal lives. However, ongoing follow-up is essential to monitor growth, neurological development, and metabolic stability. Severe cases may require lifelong dietary restrictions and medical supervision.
Complications
- Neurological damage from untreated metabolic crises.
- Developmental delays or intellectual disability.
- Recurrent metabolic acidosis or hyperammonemia.
- Potential for life-threatening complications if not managed promptly.
Lifestyle & Prevention
- Adherence to a specialized diet low in leucine.
- Avoidance of prolonged fasting or illness, which can trigger metabolic crises.
- Regular medical check-ups to adjust treatment plans as needed.
- Education for caregivers on recognizing early signs of metabolic stress.
When to Seek Professional Help
Seek immediate medical attention if symptoms such as lethargy, vomiting, or seizures occur, as these may indicate a metabolic crisis. Routine follow-up with a metabolic specialist is recommended to maintain optimal health.
Tips for Medical Coders
Document the specific subtype (E71.110) when coding for isovaleric acidemia. Include details such as the presence of metabolic crises, dietary management, or genetic confirmation to support accurate coding. Ensure documentation aligns with clinical findings to reflect the severity and management of the condition.
Medical Policies and Guidelines
Related policies from health plans
E71.110 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.